Literature DB >> 20094737

Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis?

Vimal Kumar Paliwal1, Satish Chandra, Ritu Verma, Jayantee Kalita, Usha K Misra.   

Abstract

Opsoclonus myoclonus syndrome is a rare paraneoplastic syndrome seen in 50% of children with neuroblastoma. Neural generator of opsoclonus and myoclonus is not known but evidences suggest the role of fastigial nucleus disinhibition from the loss of function of inhibitory (GABAergic) Purkinje cells in the cerebellum. We present a child with paraneoplastic opsoclonus myoclonus syndrome who responded well to clonazepam. Response to clonazepam is an evidence for the involvement of GABAergic neural circuits in the genesis of opsoclonus myoclonus syndrome and is in agreement with fastigial nucleus disinhibition hypothesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20094737     DOI: 10.1007/s00702-010-0366-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  11 in total

1.  Cerebellar activation in opsoclonus: an fMRI study.

Authors:  C Helmchen; H Rambold; A Sprenger; C Erdmann; F Binkofski
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

2.  Opsoclonus-myoclonus syndrome with abnormal single photon emission computed tomography imaging.

Authors:  K Oguro; J Kobayashi; H Aiba; H Hojo
Journal:  Pediatr Neurol       Date:  1997-05       Impact factor: 3.372

Review 3.  An update on opsoclonus.

Authors:  Agnes Wong
Journal:  Curr Opin Neurol       Date:  2007-02       Impact factor: 5.710

4.  Effective high-dose clonazepam treatment in two patients with opsoclonus and myoclonus: GABAergic hypothesis.

Authors:  Ales Bartos
Journal:  Eur Neurol       Date:  2006-10-20       Impact factor: 1.710

5.  Opsoclonus and parenchymatous degeneration of the cerebellum. The cerebellar origin of an abnormal ocular movement.

Authors:  C Ellenberger; J F Campa; M G Netsky
Journal:  Neurology       Date:  1968-11       Impact factor: 9.910

6.  Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma.

Authors:  A J Altman; R L Baehner
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

7.  Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.

Authors:  Franz Blaes; Verena Fühlhuber; Martina Korfei; Marlene Tschernatsch; Wolfgang Behnisch; Kevin Rostasy; Barbara Hero; Manfred Kaps; Klaus T Preissner
Journal:  Ann Neurol       Date:  2005-08       Impact factor: 10.422

Review 8.  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Authors:  G M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

9.  Ocular oscillations generated by coupling of brainstem excitatory and inhibitory saccadic burst neurons.

Authors:  Stefano Ramat; R John Leigh; David S Zee; Lance M Optican
Journal:  Exp Brain Res       Date:  2005-01       Impact factor: 1.972

Review 10.  The neurobiology of the opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli
Journal:  Clin Neuropharmacol       Date:  1992-06       Impact factor: 1.592

View more
  1 in total

1.  Abnormal Spontaneous Eye Movements as Initial Presentation of Organophosphate Poisoning.

Authors:  Igor De Lima Teixeira; Silméia Garcia Zanati Bazan; Arthur Oscar Schelp; Gustavo José Luvizutto; Fabrício Diniz De Lima; Rodrigo Bazan
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.